A self-report comorbidity questionnaire for haemodialysis patients

BMC Nephrology

Ken Farrington¹  Justin Roberts¹  Enric Vilar¹  Jocelyn Berdeprado²  Sivakumar Sridharan² 

[1]Health and Human Sciences Research Institute, University of Hertfordshire, Hatfield AL10 9AB, UK

[2]Renal Unit Lister Hospital, Stevenage SG1 4AB, UK

关键词: End-stage renal disease;    Survival;    Haemodialysis;    Questionnaire;    Comorbidity;   

Others  :  1082639
DOI  :  10.1186/1471-2369-15-134

 received in 2014-02-12, accepted in 2014-08-14,  发布年份 2014

【 摘 要 】

Background

Patients with end-stage renal disease (ESRD) have multiple comorbid conditions. Obtaining comorbidity data from medical records is cumbersome. A self-report comorbidity questionnaire is a useful alternative. Our aim in this study was to examine the predictive value of a self-report comorbidity questionnaire in terms of survival in ESRD patients.

Methods

We studied a prospective cross-sectional cohort of 282 haemodialysis (HD) patients in a single centre. Participants were administered the self-report questionnaire during an HD session. Information on their comorbidities was subsequently obtained from an examination of the patient’s medical records. Levels of agreement between parameters derived from the questionnaire, and from the medical records, were examined. Participants were followed-up for 18 months to collect survival data. The influence on survival of comorbidity scores derived from the self-report data (the Composite Self-report Comorbidity Score [CSCS]) and from medical records data - the Charlson Comorbidity Index [CCI] were compared.

Results

The level of agreement between the self-report items and those obtained from medical records was almost perfect with respect the presence of diabetes (Kappa score κ 0.97), substantial for heart disease and cancer (κ 0.62 and κ 0.72 respectively), moderate for liver disease (κ 0.51), only fair for lung disease, arthritis, cerebrovascular disease, and depression (κ 0.34, 0.35, 0.34 and 0.29 respectively). The CSCS was strongly predictive of survival in regression models (Nagelkerke R² value 0.202), with a predictive power similar to that of the CCI (Nagelkerke R² value 0.211). The influences of these two parameters were additive in the models – suggesting that these parameters make different contributions to the assessment of comorbidity.

Conclusion

This self-report comorbidity questionnaire is a viable tool to collect comorbidity data and may have a role in the prediction of short-term survival in patients with end-stage renal disease on haemodialysis. Further work is required in this setting to refine the tool and define its role.

【 授权许可】

   
2014 Sridharan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT: How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002, 40(1):82-89.
• [2]Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993, 341(8842):415-418.
• [3]Khan IH: Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transplant 1998, 13(Suppl 1):76-79.
• [4]Rattanasompattikul M, Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Nissenson AR, Norris KC, Kopple JD, Kalantar-Zadeh K: Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients. Int Urol Nephrol 2012, 44(6):1813-1823.
• [5]Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K: Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999, 318(7178):217-223.
• [6]Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
• [7]Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003, 14(12):3270-3277.
• [8]Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN: The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003, 49(2):156-163.
• [9]Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20(1):37-46.
• [10]Cavanaugh KL, Merkin SS, Plantinga LC, Fink NE, Sadler JH, Powe NR: Accuracy of patients’ reports of comorbid disease and their association with mortality in ESRD. Am J Kidney Dis 2008, 52(1):118-127.
• [11]Thong MSY, Kaptein AA, Benyamini Y, Krediet RT, Boeschoten EW, Dekker FW: Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis 2008, 52(1):111-117.
• [12]Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT: Predictors of poor outcome in chronic dialysis patients: the Netherlands Cooperative Study on the adequacy of dialysis. The NECOSAD Study Group. Am J Kidney Dis 2000, 35(1):69-79.
• [13]Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M: Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 2000, 283(13):1715-1722.
• [14]Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P: How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med 2000, 108(8):642-649.